MedWorld Advisors served as exclusive sell-side advisor to Unitron Group B.V. on its sale to Nolato AB. The combination brings Unitron's manufacturing capability into Nolato's global medtech platform — a strong outcome for shareholders and a strong home for the business.
The 2026 Top 10 Companies list is less a ranking than a map of an industry transforming itself in public.
Capability-building medtech acquisitions are more relevant to the market than headline-grabbing transformational ones. Read more in our column, MedTech Mindset, in Today’s Medical Developments Magazine.
The most important takeaway from the 2026 MPO Top 30 report is not embedded in any one transaction but rather the pattern among the ranked firms.
The conversation at FMMC mirrored some of the discussions taking place in deal rooms this year.
Medtech companies must assess where artificial intelligence creates value at each stage of the product lifecycle.
Watch Dave Sheppard give the 2026 ODT Forum State of the Industry. This session provides a comprehensive overview of the happenings within the orthopedic device manufacturing industry. Supply chain, M&A, and other related topics critical to both OEMs and their supply partners are covered.
Rewatch our webinar with Today’s Medical Developments as we explore the value impacts of AI in MedTech in 2026 for MedTech companies at all stages of growth – from start-up to scale-up including operational excellence through M&A Exit.
The $75 billion orthopedic market is growing, but pricing pressure throughout the supply chain is intensifying.
While AI is a fantastic tool to use during M&A transactions, it doesn’t replace the situational intelligence provided by human transaction advisors.